These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36645634)

  • 1. Temporal and spatial stability of the EM/PM molecular subtypes in adult diffuse glioma.
    Feng J; Zhao Z; Wei Y; Bao Z; Zhang W; Wu F; Li G; Sun Z; Tan Y; Li J; Zhang Y; Duan Z; Qi X; Yu K; Cong Z; Yang J; Wang Y; Sun Y; Tang F; Su X; Fang C; Jiang T; Fan X
    Front Med; 2023 Apr; 17(2):240-262. PubMed ID: 36645634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTBP1-mediated repression of neuron-specific CDC42 splicing constitutes a genomic alteration-independent, developmentally conserved vulnerability in IDH-wildtype glioblastoma.
    Yang J; Feng J; Lv J; Chu X; Wei Y; Zhang Y; Li J; Sun Y; Li G; Jiang T; Huang J; Fan X
    Funct Integr Genomics; 2024 Aug; 24(4):135. PubMed ID: 39117866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A glioma classification scheme based on coexpression modules of EGFR and PDGFRA.
    Sun Y; Zhang W; Chen D; Lv Y; Zheng J; Lilljebjörn H; Ran L; Bao Z; Soneson C; Sjögren HO; Salford LG; Ji J; French PJ; Fioretos T; Jiang T; Fan X
    Proc Natl Acad Sci U S A; 2014 Mar; 111(9):3538-43. PubMed ID: 24550449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individual Assignment of Adult Diffuse Gliomas into the EM/PM Molecular Subtypes Using a TaqMan Low-Density Array.
    Li J; Xue Y; Wenger A; Sun Y; Wang Z; Zhang C; Zhang Y; Fekete B; Rydenhag B; Jakola AS; Jiang T; Carén H; Fan X
    Clin Cancer Res; 2019 Dec; 25(23):7068-7077. PubMed ID: 31481507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmental origins and oncogenic pathways in malignant brain tumors.
    Lu QR; Qian L; Zhou X
    Wiley Interdiscip Rev Dev Biol; 2019 Jul; 8(4):e342. PubMed ID: 30945456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paradoxical prognostic impact of TERT promoter mutations in gliomas depends on different histological and genetic backgrounds.
    You H; Wu Y; Chang K; Shi X; Chen XD; Yan W; Li R
    CNS Neurosci Ther; 2017 Oct; 23(10):790-797. PubMed ID: 28868656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
    Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q
    BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterizing temporal genomic heterogeneity in pediatric high-grade gliomas.
    Salloum R; McConechy MK; Mikael LG; Fuller C; Drissi R; DeWire M; Nikbakht H; De Jay N; Yang X; Boue D; Chow LML; Finlay JL; Gayden T; Karamchandani J; Hummel TR; Olshefski R; Osorio DS; Stevenson C; Kleinman CL; Majewski J; Fouladi M; Jabado N
    Acta Neuropathol Commun; 2017 Oct; 5(1):78. PubMed ID: 29084603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic, cellular, and connectomic characterization of the brain regions commonly plagued by glioma.
    Mandal AS; Romero-Garcia R; Hart MG; Suckling J
    Brain; 2020 Dec; 143(11):3294-3307. PubMed ID: 33278823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent hypermethylation of DNMT1, MGMT and EGFR genes in progression of gliomas.
    Gömöri E; Pál J; Kovács B; Dóczi T
    Diagn Pathol; 2012 Jan; 7():8. PubMed ID: 22264301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissecting human gliomas by single-cell RNA sequencing.
    Tirosh I; Suvà ML
    Neuro Oncol; 2018 Jan; 20(1):37-43. PubMed ID: 29016805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery.
    Cimino PJ; Zager M; McFerrin L; Wirsching HG; Bolouri H; Hentschel B; von Deimling A; Jones D; Reifenberger G; Weller M; Holland EC
    Acta Neuropathol Commun; 2017 May; 5(1):39. PubMed ID: 28532485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Distinct DNA Methylation Shift in a Subset of Glioma CpG Island Methylator Phenotypes during Tumor Recurrence.
    de Souza CF; Sabedot TS; Malta TM; Stetson L; Morozova O; Sokolov A; Laird PW; Wiznerowicz M; Iavarone A; Snyder J; deCarvalho A; Sanborn Z; McDonald KL; Friedman WA; Tirapelli D; Poisson L; Mikkelsen T; Carlotti CG; Kalkanis S; Zenklusen J; Salama SR; Barnholtz-Sloan JS; Noushmehr H
    Cell Rep; 2018 Apr; 23(2):637-651. PubMed ID: 29642018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligodendrocyte Progenitor Cells and Macrophages/Microglia Produce Glioma Stem Cell Niches at the Tumor Border.
    Hide T; Komohara Y; Miyasato Y; Nakamura H; Makino K; Takeya M; Kuratsu JI; Mukasa A; Yano S
    EBioMedicine; 2018 Apr; 30():94-104. PubMed ID: 29559295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-expression modules of NF1, PTEN and sprouty enable distinction of adult diffuse gliomas according to pathway activities of receptor tyrosine kinases.
    Zhang W; Lv Y; Xue Y; Wu C; Yao K; Zhang C; Jin Q; Huang R; Li J; Sun Y; Su X; Jiang T; Fan X
    Oncotarget; 2016 Sep; 7(37):59098-59114. PubMed ID: 27385209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and clinicopathologic characteristics of the molecular subtypes in malignant glioma: a multi-institutional analysis of 941 cases.
    Lin N; Yan W; Gao K; Wang Y; Zhang J; You Y
    PLoS One; 2014; 9(4):e94871. PubMed ID: 24755548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glioma through the looking GLASS: molecular evolution of diffuse gliomas and the Glioma Longitudinal Analysis Consortium.
    GLASS Consortium
    Neuro Oncol; 2018 Jun; 20(7):873-884. PubMed ID: 29432615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular subtypes of glioma identified by genome-wide methylation profiling.
    Kloosterhof NK; de Rooi JJ; Kros M; Eilers PH; Sillevis Smitt PA; van den Bent MJ; French PJ
    Genes Chromosomes Cancer; 2013 Jul; 52(7):665-74. PubMed ID: 23629961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subtyping of gliomas of various WHO grades by the application of immunohistochemistry.
    Popova SN; Bergqvist M; Dimberg A; Edqvist PH; Ekman S; Hesselager G; Ponten F; Smits A; Sooman L; Alafuzoff I
    Histopathology; 2014 Feb; 64(3):365-79. PubMed ID: 24410805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Histological and molecular classification of gliomas].
    Figarella-Branger D; Colin C; Coulibaly B; Quilichini B; Maues De Paula A; Fernandez C; Bouvier C
    Rev Neurol (Paris); 2008; 164(6-7):505-15. PubMed ID: 18565348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.